196 related articles for article (PubMed ID: 30362577)
1. Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
Griffith LM; VanRaden M; Barrett AJ; Childs RW; Fowler DH; Kang EM; Tisdale JF; Klein HG; Stroncek DF
Transfusion; 2019 Jan; 59(1):303-315. PubMed ID: 30362577
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Karanes C; Wang S
Transfusion; 2020 Oct; 60(10):2225-2242. PubMed ID: 32743866
[TBL] [Abstract][Full Text] [Related]
3. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Wang S
Transfusion; 2019 Nov; 59(11):3371-3385. PubMed ID: 31599972
[TBL] [Abstract][Full Text] [Related]
4. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
Subramanian S; Cohn C; DeFor T; Welbig J; Brunstein C; El Jurdi N; Weisdorf D
Transfusion; 2021 Jul; 61(7):2064-2074. PubMed ID: 33899243
[TBL] [Abstract][Full Text] [Related]
5. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R
Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562
[TBL] [Abstract][Full Text] [Related]
6. Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation.
Kurosawa S; Yamaguchi T; Nakabayashi S; Kasane M; Tsubokura M; Iwashita N; Minakawa Y; Ohtake R; Kawamura K; Nishioka Y; Takeda W; Hirakawa T; Aoki J; Ito A; Tanaka T; Inamoto Y; Kim SW; Kojima M; Takanashi M; Fukuda T
Int J Hematol; 2021 Apr; 113(4):518-529. PubMed ID: 33392973
[TBL] [Abstract][Full Text] [Related]
7. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD; Koff JL; Khoury HJ; Langston AA; Zimring JC; Roback JD; Giver CR
Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
[TBL] [Abstract][Full Text] [Related]
8. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.
Vande Vusse LK; Madtes DK; Guthrie KA; Gernsheimer TB; Curtis JR; Watkins TR
Transfusion; 2014 Apr; 54(4):1071-80. PubMed ID: 24033082
[TBL] [Abstract][Full Text] [Related]
9. Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
Zhang X; Xiao Y; Ran Q; Liu Y; Duan Q; Duan H; Ye X; Li Z
PLoS One; 2012; 7(5):e36912. PubMed ID: 22701516
[TBL] [Abstract][Full Text] [Related]
10. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
11. Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.
Solh M; Brunstein C; Morgan S; Weisdorf D
Biol Blood Marrow Transplant; 2011 May; 17(5):710-6. PubMed ID: 20813199
[TBL] [Abstract][Full Text] [Related]
12. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
13. Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis.
Liesveld J; Pawlowski J; Chen R; Hyrien O; Debolt J; Becker M; Phillips G; Chen Y
Bone Marrow Transplant; 2013 May; 48(5):691-7. PubMed ID: 23085827
[TBL] [Abstract][Full Text] [Related]
14. Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
Goel R; Nellis ME; Karam O; Hanson SJ; Tormey CA; Patel RM; Birch R; Sachais BS; Sola-Visner MC; Hauser RG; Luban NLC; Gottschall J; Josephson CD; Hendrickson JE; Karafin MS;
Transfusion; 2021 Sep; 61(9):2589-2600. PubMed ID: 34455598
[TBL] [Abstract][Full Text] [Related]
15. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
Atay D; Erbey F; Akcay A; Ozturk G
Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
[TBL] [Abstract][Full Text] [Related]
16. Age, CD34+ cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation.
Regalado-Artamendi I; García-Fasanella M; Medina L; Fernandez-Sojo J; Esquirol A; García-Cadenas I; Martino R; Briones J; Sierra J; Novelli S
Vox Sang; 2023 Aug; 118(8):681-689. PubMed ID: 37356813
[TBL] [Abstract][Full Text] [Related]
17. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
18. Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.
Solves P; Carpio N; Balaguer A; Romero S; Iacoboni G; Gómez I; Lorenzo I; Moscardó F; Sanz J; Lopez F; Martin G; Jarque I; Montesinos P; De La Rubia J; Sanz G; Sanz MA
Blood Transfus; 2015 Jul; 13(3):411-6. PubMed ID: 25761311
[TBL] [Abstract][Full Text] [Related]
19. Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Jarisch A; Salzmann-Manrique E; Soerensen J; Sach G; Rettinger E; Willasch A; Bakhtiar S; Klarmann D; Bräuninger S; Moser L; Fekadu J; Hutter M; Klingebiel T; Klusmann JH; Bader P; Bonig H
Br J Haematol; 2023 Jun; 201(6):1159-1168. PubMed ID: 36949601
[TBL] [Abstract][Full Text] [Related]
20. Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patients.
Yuan S; Yang D; Nakamura R; Al Malki MM; Salhotra A; Afkhami M; Wang S
Transfusion; 2024 Feb; 64(2):255-280. PubMed ID: 38225215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
